ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 84 filers reported holding ALBIREO PHARMA INC in Q2 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $13,974,000 | -25.4% | 600,000 | 0.0% | 0.38% | -9.5% |
Q3 2021 | $18,720,000 | -11.3% | 600,000 | 0.0% | 0.42% | -2.1% |
Q2 2021 | $21,108,000 | -0.2% | 600,000 | 0.0% | 0.43% | +14.4% |
Q1 2021 | $21,150,000 | -19.5% | 600,000 | -14.3% | 0.37% | -33.7% |
Q4 2020 | $26,257,000 | -7.6% | 700,000 | -17.8% | 0.56% | -18.3% |
Q3 2020 | $28,411,000 | +114.3% | 851,405 | +70.2% | 0.69% | +86.0% |
Q2 2020 | $13,255,000 | +37.7% | 500,360 | -14.9% | 0.37% | -8.8% |
Q1 2020 | $9,628,000 | -15.9% | 588,125 | +30.6% | 0.41% | -7.9% |
Q4 2019 | $11,444,000 | +27.1% | 450,200 | 0.0% | 0.44% | +22.4% |
Q3 2019 | $9,004,000 | -37.9% | 450,200 | +0.0% | 0.36% | -38.5% |
Q2 2019 | $14,508,000 | -9.9% | 450,000 | -10.0% | 0.59% | -10.8% |
Q1 2019 | $16,105,000 | +31.3% | 500,000 | 0.0% | 0.66% | +44.9% |
Q4 2018 | $12,265,000 | -25.6% | 500,000 | 0.0% | 0.45% | +5.8% |
Q3 2018 | $16,480,000 | -7.2% | 500,000 | 0.0% | 0.43% | +13.8% |
Q2 2018 | $17,750,000 | -0.5% | 500,000 | -8.7% | 0.38% | +69.1% |
Q1 2018 | $17,843,000 | +132.3% | 547,841 | +82.6% | 0.22% | +92.2% |
Q4 2017 | $7,680,000 | – | 300,000 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |